Novo Nordisk now has more than 130,000 weight-loss prescriptions as it hikes financial outlook

MarketWatch

Novo Nordisk said its Wegovy injectable drug for weight loss now has more than 130,000 weekly prescriptions in North America alone after boosting supplies to meet insatiable demand.

The Stock Market News

The Stock Market News is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global economy and business, trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs & funds, bonds & rates and much more. The Stock Market News works with public RSS feeds of the best business, finance and economic news websites, personal blogs providing automatically generated list of financial news links referring to its sources. Disclaimer: By using any material of this website, you acknowledge and agree that The Stock Market News is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.